Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations
ZA Stacy, SK Richter - Therapeutic Advances in …, 2018 - journals.sagepub.com
Background: To review data from the pivotal phase III trials evaluating the efficacy and safety
of direct oral anticoagulants (DOACs) versus warfarin for stroke prevention in patients with …
of direct oral anticoagulants (DOACs) versus warfarin for stroke prevention in patients with …
Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations
ZA Stacy, SK Richter - Therapeutic Advances in …, 2018 - collections.uhsp.edu
Background: To review data from the pivotal phase III trials evaluating the efficacy and safety
of direct oral anticoagulants (DOACs) versus warfarin for stroke prevention in patients with …
of direct oral anticoagulants (DOACs) versus warfarin for stroke prevention in patients with …
[HTML][HTML] Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations
ZA Stacy, SK Richter - Therapeutic Advances in Cardiovascular …, 2018 - ncbi.nlm.nih.gov
Background: To review data from the pivotal phase III trials evaluating the efficacy and safety
of direct oral anticoagulants (DOACs) versus warfarin for stroke prevention in patients with …
of direct oral anticoagulants (DOACs) versus warfarin for stroke prevention in patients with …
[引用][C] Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations
ZA Stacy, SK Richter - Therapeutic Advances in Cardiovascular Disease, 2018 - elibrary.ru
Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations
ZA Stacy, SK Richter - Therapeutic advances in …, 2018 - pubmed.ncbi.nlm.nih.gov
Background To review data from the pivotal phase III trials evaluating the efficacy and safety
of direct oral anticoagulants (DOACs) versus warfarin for stroke prevention in patients with …
of direct oral anticoagulants (DOACs) versus warfarin for stroke prevention in patients with …
Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations.
ZA Stacy, SK Richter - Therapeutic Advances in Cardiovascular …, 2018 - europepmc.org
Background To review data from the pivotal phase III trials evaluating the efficacy and safety
of direct oral anticoagulants (DOACs) versus warfarin for stroke prevention in patients with …
of direct oral anticoagulants (DOACs) versus warfarin for stroke prevention in patients with …
[PDF][PDF] Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations
ZA Stacy, SK Richter - 2018 - researchgate.net
Background: To review data from the pivotal phase III trials evaluating the efficacy and safety
of direct oral anticoagulants (DOACs) versus warfarin for stroke prevention in patients with …
of direct oral anticoagulants (DOACs) versus warfarin for stroke prevention in patients with …
Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations.
ZA Stacy, SK Richter - Therapeutic Advances in …, 2018 - search.ebscohost.com
Background: To review data from the pivotal phase III trials evaluating the efficacy and safety
of direct oral anticoagulants (DOACs) versus warfarin for stroke prevention in patients with …
of direct oral anticoagulants (DOACs) versus warfarin for stroke prevention in patients with …